Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.42 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.42 |
| ▸ | LGALS4 | P56470 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL222100 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL420134 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL15963882 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL1310354 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL7870044 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL15961754 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL513822 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL15961758 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL15963878 | 1.00 | MAOB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT | |
| SCHEMBL9733602 | 0.96 | THRB (0.44) | MAOBL3MBTL1MAPK1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1957592-B1 | AQUEOUS COATING COMPOSITION WITH LOW VOC CONTENT | BASF SE (DE) | 2012-03-07 | — | — | EP | claimed |
| US-7858682-B2 | Aqueous coating composition with low VOC content | BASF AKTIENGESELLSCHAFT (DE) | 2010-12-28 | — | — | US | claimed |
| US-20080262145-A1 | While maintaining freeze-thaw stability of latex paints; a hydroxy-functional (meth)acrylate or (meth)allyl ether binder, a pigment, and an antifrost agent; environmentally friendly | BASF SE (DE) | 2008-10-23 | — | — | US | claimed |
| EP-1957592-A1 | AQUEOUS COATING COMPOSITION WITH LOW VOC CONTENT | BASF SE (DE) | 2008-08-20 | — | — | EP | claimed |
| WO-2007060118-A1 | AQUEOUS COATING COMPOSITION WITH LOW VOC CONTENT | BASF SE (DE) | 2007-05-31 | — | — | WO | claimed |
| US-20220218827-A1 | DELIVERY OF THERAPEUTIC COMPOUNDS WITH IRON OXIDE NANOPARTICLES | UNITED STATES GOVERNMENT | 2022-07-14 | — | — | US | disclosed |
| US-10696995-B2 | Enzymatic production of glycosylated synthons | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2020-06-30 | — | — | US | disclosed |
| US-20180258456-A1 | Enzymatic Production of Glycosylated Synthons | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2018-09-13 | — | — | US | disclosed |
| EP-3271469-A1 | ENZYMATIC PRODUCTION OF GLYCOSYLATED SYNTHONS | Institut National De La Recherche Agronomique (INRA) (FR) | 2018-01-24 | — | — | EP | disclosed |
| WO-2016146764-A1 | ENZYMATIC PRODUCTION OF GLYCOSYLATED SYNTHONS | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) | 2016-09-22 | — | — | WO | disclosed |
| US-20150231269-A1 | DELIVERY OF THERAPEUTIC COMPOUNDS WITH IRON OXIDE NANOPARTICLES | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2015-08-20 | — | — | US | disclosed |
| WO-2014047318-A1 | DELIVERY OF THERAPEUTIC COMPOUNDS WITH IRON OXIDE NANOPARTICLES | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2014-03-27 | — | — | WO | disclosed |
| US-8257932-B2 | Complexes comprising glycosylated nanostructures, which bind selectively to cells expressing glycosylated surface molecules recognized by the lectin; carbon nanotube functionalized with lipid, linked to a polymer bearing repeated alpha-N-acetylgalactosamine sugar groups | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-09-04 | — | — | US | disclosed |
| US-20120088934-A1 | OLIGOMER FUNCTIONALIZED NANOTUBES AND COMPOSITES FORMED THEREWITH | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-04-12 | — | — | US | disclosed |
| US-7858682-B2 | Aqueous coating composition with low VOC content | BASF AKTIENGESELLSCHAFT (DE) | 2010-12-28 | — | — | US | disclosed |
| US-20080262145-A1 | While maintaining freeze-thaw stability of latex paints; a hydroxy-functional (meth)acrylate or (meth)allyl ether binder, a pigment, and an antifrost agent; environmentally friendly | BASF SE (DE) | 2008-10-23 | — | — | US | disclosed |
| US-20080199399-A1 | Interfacing Nanostructures to Biological Cells | ENERGY, UNITED STATES DEPARTMENT OF | 2008-08-21 | — | — | US | disclosed |
| EP-1957592-A1 | AQUEOUS COATING COMPOSITION WITH LOW VOC CONTENT | BASF SE (DE) | 2008-08-20 | — | — | EP | disclosed |
| WO-2007060118-A1 | AQUEOUS COATING COMPOSITION WITH LOW VOC CONTENT | BASF SE (DE) | 2007-05-31 | — | — | WO | disclosed |
| US-5886109-A | AZO group-containing high molecular weight compound for block copolymerization | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1999-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088934-A1 | OLIGOMER FUNCTIONALIZED NANOTUBES AND COMPOSITES FORMED THEREWITH | TNS4, ILK, PFAS | MAOB 858/4885L3MBTL1 2184/4885MAPK1 3572/4885 |
| US-20080199399-A1 | Interfacing Nanostructures to Biological Cells | EPCAM, LGALS2, LGALS1 | MAOB 3745/4885L3MBTL1 413/4885MAPK1 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.